1 minute read
Mar. 12, 2022
GCC5694A
oral SGLT2 inhibitor Clinical candidate for diabetes from literature SGLT2 inhibitor Bioorganic Med. Chem. Lett. GC Pharma (Green Cross)
oral SGLT2 inhibitor Clinical candidate for diabetes from literature SGLT2 inhibitor Bioorganic Med. Chem. Lett. GC Pharma (Green Cross)